2 research outputs found
Insulin therapy for type 2 diabetes
- Author
- A Fritsche
- A Wright
- AE Butler
- Afshin Sasali
- B Zhang
- C Abraira
- C Weyer
- Clinical practice recommendations 2003. American Diabetes Association
- DE DeWitt
- DE DeWitt
- DM Nathan
- Economic costs of diabetes in the U.S. in 2002. American Diabetes Association
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group
- EL Air
- FJ Cohen
- H Ilkova
- H Yki-Järvinen
- H Yki-Järvinen
- IA Harsch
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group
- J Rosenstock
- J Rosenstock
- J-P Després
- JA Kiayias
- Jack L. Leahy
- JB Saaddine
- JE Gerich
- JF Yale
- JL Chan
- JR White
- JS Skyler
- K Kosaka
- K Malmberg
- K Malmberg
- L Avilés-Santa
- M Henricsson
- M Kipnes
- M Korytkowski
- MC Riddle
- MC Riddle
- MC Riddle
- MC Riddle
- MG Wulffelé
- Overview of 6 years therapy of type 2 diabetes: a progressive disease (UKPDS 16). UK Prospective Diabetes Study (UKPDS) Group
- P Dandona
- P Gaede
- P Zimmet
- PA Hollander
- PE Cryer
- RC Turner
- SE Inzucchi
- SM Strowig
- WT Cefalu
- WT Cefalu
- WT Garvey
- Yki-Järvinen
- Publication venue
- 'Springer Science and Business Media LLC'
- Publication date
- Field of study
No full textDo angiotensin II antagonists provide benefits beyond blood pressure reduction?
- Author
- 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension
- A Breckenridge
- A Hoieggen
- A Holmgren
- A Kabour
- A Mahmud
- A Remuzzi
- A Remuzzi
- AA Eddy
- ACE Inhibitors in Diabetic Nephropathy Trialists’ group
- AJ Manolis
- American Diabetes Association: clinical practice recommendations
- AV Chobanian
- AV Kshirsagar
- B Carlberg
- B Dahlof
- B Dahlof
- B Dahlof
- B Lopez
- B Neal
- B Schieffer
- B Williams
- BM Brenner
- BM Brenner
- BM Psaty
- C Bengtsson
- C Fernandez-Andrade
- C Kramer
- CM Ferrario
- D Castillo del
- D Levy
- DJ Leehey
- DS Freedman
- E Esmatjes
- E Liberopoulos
- EJ Lewis
- EL Schiffrin
- EL Schiffrin
- F Angeli
- F Turnbull
- FC Luft
- FS Nielsen
- G Minghelli
- GJ Hankey
- GL Bakris
- GL Baumbach
- H Brasch
- H Holdaas
- H Ibsen
- H Lithell
- Heart Outcomes Prevention Evaluation Study Investigators
- HH Parving
- HJ Manley
- J Ahmad
- J Sadoshima
- JA Cutler
- Jacques de Champlain
- JG Puig
- JI Guerra-Cuesta
- JM Edelman
- JM Proudfoot
- JT Moriarity
- K Hebert
- K Iwami
- K Kaneko
- K Sharma
- K Wachtell
- L Hansson
- L Hansson
- L Hansson
- L Kalinowski
- L Mazzolai
- LH Lindholm
- LH Opie
- LM Wing
- LV d’Uscio
- M Burnier
- M Fukuhara
- M Monton
- M Ravid
- M Sasaki
- M Schupp
- M Schwemmer
- MA Laplante
- MH Alderman
- MH Alderman
- MH Olsen
- MJ Brown
- MJ Koren
- OK Andersson
- P Li
- P Li
- P Li
- P Magri
- P Paradis
- P Ruggenenti
- P Sleight
- P Svensson
- P Verdecchia
- P Verdecchia
- PC Deedwania
- PJ Levy
- R Agarwal
- R Collins
- R Devereux
- R Fogari
- R Fogari
- R Klein
- RA Rodby
- RG Hart
- RM Touyz
- RO Estacio
- RT Gansevoort
- S Julius
- S Julius
- S Kagami
- S Laurent
- S Rajagopalan
- S Yusuf
- SC Amuchastegui
- SC Benson
- T Hamada
- T Sayin
- TW Gress
- UK Prospective Diabetes Study Group
- VL Serebruany
- WB Strawn
- Y Erdem
- Y Lacourciere
- Publication venue
- 'Springer Science and Business Media LLC'
- Publication date
- Field of study
No full text
